or immune-mediated vasculitis, and sequestration or margination of platelets in infection, with E canis, RMSF, bartonellosis and possibly anaplasmosis , Wong and Thomas 1998 , Harrus and others 1999 .
At the University of California Davis Veterinary Medical Teaching Hospital, the two most common indications for testing with a 'tick panel' are thrombocytopenia and polyarthritis. The aim of this study was to determine whether the prevalence of tickborne pathogens would be increased in dogs with polyarthritis and/or thrombocytopenia.
A case-control design was used to evaluate this hypothesis. A secondary goal of the study was to describe regional and demographic risks for serological and PCR-positive results. A panel testing for all suspected canine tickborne diseases was administered to 110 dogs seen at the hospital with signs of thrombocytopenia, polyarthritis, or both, and to 110 control dogs randomly chosen from dogs seen at the hospital on the same day as the case dog.
The location of the dog's residence, based on the owner's address, was grouped as follows: coast range mountains (a set of mountain ranges from 304 to 1700 m, with a climate varying from temperate rainforest to Mediterranean, extending from the coast to 50 km inland, from the Oregon border southwards to near the Los Angeles area), the hot dry Central Valley (extending north to south between the coast ranges and the Sierra Nevada mountains), the Sierra Nevada mountains (along the eastern state boundary), and out-ofstate regions (including two dogs from Nevada and one from Oregon Complete blood counts were performed using an automated instrument (Serono Baker 9000; Biochemical Immunosystems). Differential cell counts were performed manually from thin Wright-stained blood smears. Serology for A phagocytophilum and B vinsonii berkhoffii was performed as described by Dumler and others (1995) and Chang and others (2000) . Antibodies to E canis and R rickettsii were assayed by an immunofluorescence assay (IFA) with commercial slides (Protatek) as for A phagocytophilum. IFA for B burgdorferi was performed using commercial slides (VMRD); positive sera were confirmed by Western blot, and interpreted according to CDC guidelines (CDC 1995), except that three or more diagnostic bands were considered positive and the presence of bands at 31 and 34 kDa was considered evidence of vaccine exposure.
DNA was extracted from whole blood (DNeasy Tissue kit; Qiagen), and TaqMan PCR systems for A phagocytophilum and B burgdorferi were run as described previously others 1999, Pusterla and others 1999) . The PCR for E canis used primers Ec.139f 5´-ATG GCT ATT CCG TAC TACTAGGTAGATTC-3´, Ec.32r 5´-CATGCAAGTCGAACGGACAAT-3´ and an internal, fluorescent-labelled TaqMan probe Ec.61p 5´-TCT GCC ACT AACAATTTCCTATAGCCAGAGGC-6-carboxy-tetramethyl-rhodamine. The results of all TaqMan PCR assays were considered positive if the C t value was less than or equal to 25. For B vinsonii berkhoffii and R rickettsii, PCR was performed Table 3) as described previously (Regnery and others 1991 , Chang and others 2000 , Chomel and others 2001 .
The breeds and locations of the dogs are given in Table 1 . There were 56 dogs with polyarthritis and 54 with thrombocytopenia, with an overall prevalence of tickborne disease in the two groups of 26·8 per cent and 25·9 per cent, respectively. The prevalence of tickborne disease in the controls was 6 per cent. The difference between the overall prevalence in dogs with thrombocytopenia and those with polyarthritis was not statistically significant, but when grouped together, the case dogs had significantly more exposure than the controls (P=0·002). Packed-cell volume differed significantly between the cases and controls (P=0·003), but location, serum protein and total leucocytes did not (Tables 1, 2) . Serology for A phagocytophilum and E canis exposure documented prevalences of 5 per cent and 1 per cent, respectively, in all the dogs (Table 3) . Three A phagocytophilum and one E canis PCR-positive dogs were detected in the case group. No dogs were B vinsonii berkhoffii or R rickettsii PCR-positive. The seroprevalence for RMSF, B burgdorferi (both vaccine positive and due to natural exposure), and B vinsonii berkhoffii ranged from 1 to 4 per cent. Regional seroprevalence and odds ratios of serological tests and case status were not statistically significant. Nevertheless, 12 probable and six possible cases of tickborne disease were identified retrospectively based on clinical signs, serology and PCR, including seven that had been overlooked at the time of treatment (Table 4) .
Despite a relatively high serological and PCR prevalence of tickborne disease among dogs tested in this study, neither PCR nor serology for any single pathogen was significantly associated with polyarthritis or thrombocytopenia. The lack of a statistical association between case and specific test status in this study was due to the frequent presence of active infection in the absence of clinical signs (test-positive controls), as well as the high proportion of case dogs with other aetiologies (test-negative cases, aetiologies often not determined) that accounted for the clinical signs. In addition, the relatively small sample size and other factors may have been important, since a weak association of these cases may have been discovered with a sufficiently large sample size. Importantly, the diagnosis of tickborne disease was overlooked in many dogs, in part because of their failure to show clinical signs and also because of the initial choice by the clinicians to apply no or few diagnostic tests for tickborne disease rather than a comprehensive panel. The results of this study suggest that comprehensive testing for tickborne disease in certain cases is very important; however, there remains a high likelihood that other, non-tick-transmitted diseases will be the cause of polyarthritis or thrombocytopenia in many cases.
Because odds ratios were not significant, the overall prevalence for each pathogen was calculated, grouping cases and controls in order to describe regional and demographic trends for risk of infection. Breed and residence location were not risk factors, although both can be important determinants of tickborne disease. In California, the northern coast ranges and western foothills of the Sierra Nevada mountains are the most affected by tickborne disease, with desert and valley locations being typically too hot and dry for I pacificus, therefore providing a low risk for infection (CDC 2001 , Foley and others 2001 , 2004b , Hoar and others 2003 . Cases of Lyme disease have been reported in dogs from northern California (Foley and others 2004b) , although confirming a diagnosis may be difficult. Evaluating Western blots, in particular the vaccine-associated 31 and 34 kDa bands, is helpful in this regard (Barthold and others 1995) .
The three dogs in the present study with possible monocytic ehrlichiosis included one suspect exposure based only on serology, one probable case with a high titre and consistent clinical signs of late-stage ehrlichiosis, and one confirmed case with glomerulonephritis, lameness, lymphadenopathy and anaemia, but an anomalously low titre despite being PCR positive. Confirming a diagnosis of this disease can be critically important because it is treatable in the early stages but can result in chronic and fatal progressive glomerulonephritis in some cases (Neer 1999) . Little information exists regarding the overall prevalence and spatial distribution of this disease in California. The seroprevalence of B vinsonii berkhoffii, reported previously as less than 3 per cent (Henn and others 2005) , was also low in the present study, although rates as high as 93 per cent have been described for a heavily tick-infested kennel population of dogs in North Carolina (Kordick and others 1999a) . Despite low exposure risk, this disease remains a very important cause of cardiac disease in dogs (Henn and others 2005) .
In summary, a minimum estimate of 20 per cent of dogs with thrombocytopenia or polyarthritis in a population from California had evidence of exposure to tickborne diseases. The data presented in this study should assist clinicians considering vectorborne diseases as a differential diagnosis of canine health problems, and, in general, should help to broaden knowledge of the scope of sequelae of infection with B burgdorferi, A phagocytophilum, R rickettsii and B vinsonii berkhoffii. Because these diseases may produce severe clinical manifestations, ongoing evaluations are warranted, particularly in dogs in known enzootic regions.
